What is it about?

In this study, we find that administering a GluK5 antagonist within 20 minutes of a nerve agent exposure will prevent long term deficits in synaptic plasticity, and will prevent the associated increases in anxiety-like behavior.

Featured Image

Why is it important?

This work is important because it provides a novel treatment option to prevent long term deficits after a nerve agent exposure.

Read the Original

This page is a summary of: LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety, Neuropharmacology, February 2015, Elsevier,
DOI: 10.1016/j.neuropharm.2014.08.014.
You can read the full text:

Read

Contributors

The following have contributed to this page